Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs
Header Skipped.
The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
Brigham and Women's Hospital received an 'A' Leapfrog Hospital Safety Grade for the spring of 2022, The Leapfrog Group announced today. Read More...
By mapping the cell types and genes expressed in the human and mouse trigeminal ganglion, researchers have created an online resource for studying the molecular basis of headache and facial pain Read More...
The first large-scale trial to test the long-term effects of a cocoa flavanol supplement to prevent cardiovascular disease offers promising signals that cocoa flavanols could have protective cardiovascular effects. Read More...
